Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVir Biotechnology Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$8.21 | $7.54 | -$0.10 |
| Q2 2026 | 4 | $0.19 | $0.58 | $0.33 |
| Q3 2026 | 4 | -$1.01 | -$0.61 | -$0.75 |
| Q4 2026 | 2 | -$1.68 | $0.21 | -$0.65 |
| Q1 2027 | 2 | -$1.25 | $0.16 | -$0.48 |
| Q2 2027 | 1 | -$1.82 | $0.23 | -$0.70 |
| Q3 2027 | 1 | -$1.54 | $0.19 | -$0.60 |
| Q4 2027 | 2 | -$1.69 | $0.21 | -$0.65 |
| Q1 2028 | 3 | -$1.01 | $0.13 | -$0.39 |
| Q2 2028 | 2 | -$1.04 | $0.13 | -$0.40 |
| Q3 2028 | 2 | -$1.37 | $0.17 | -$0.53 |
| Q4 2028 | 3 | -$1.35 | $0.17 | -$0.52 |
Vir Biotechnology Inc Earnings Date And Information
Vir Biotechnology Inc last posted its earnings results on Wednesday, August 5th, 2026. The company reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.3326 by $0.1374. The company had revenue of 238.95 M for the quarter and had revenue of 68.56 M for the year. Vir Biotechnology Inc has generated $-3 earnings per share over the last year ($-3.16 diluted earnings per share) and currently has a price-to-earnings ratio of -4.74. Vir Biotechnology Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Vir Biotechnology Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2026 | Q2 2026 | $0.33 | $0.48 | 0.15 | $135.88 M | $238.95 M |
| 05/06/2026 | Q1 2026 | N/A | -$0.85 | N/A | $55.49 M | $-29,000 |
| 02/23/2026 | Q4 2025 | -$0.42 | -$0.31 | 0.11 | $19.91 M | $64.07 M |
| 11/05/2025 | Q3 2025 | -$0.70 | -$1.17 | -0.47 | $1.98 M | $240.00 K |
| 08/06/2025 | Q2 2025 | -$0.72 | -$0.80 | -0.08 | $2.72 M | $1.21 M |
| 05/07/2025 | Q1 2025 | N/A | -$0.88 | N/A | $8.59 M | $3.03 M |
| 02/26/2025 | Q4 2024 | N/A | -$0.76 | N/A | $8.17 M | $12.37 M |
| 11/04/2024 | Q3 2024 | N/A | -$1.56 | N/A | $5.54 M | $2.38 M |
| 08/01/2024 | Q2 2024 | -$0.93 | -$1.02 | -0.09 | $7.53 M | $3.08 M |
| 05/03/2024 | Q1 2024 | N/A | -$0.48 | N/A | $11.71 M | $56.38 M |
| 02/26/2024 | Q4 2023 | N/A | -$0.86 | N/A | $11.18 M | $16.79 M |
| 11/03/2023 | Q3 2023 | N/A | -$1.22 | N/A | $8.71 M | $2.64 M |
| 08/04/2023 | Q2 2023 | N/A | -$1.45 | N/A | $22.39 M | $3.80 M |
| 05/08/2023 | Q1 2023 | N/A | -$1.06 | N/A | $50.15 M | $62.96 M |
| 02/28/2023 | Q4 2022 | N/A | -$0.76 | N/A | $149.61 M | $49.41 M |
| 11/03/2022 | Q3 2022 | -$0.21 | $1.32 | 1.53 | $114.22 M | $374.56 M |
| 08/09/2022 | Q2 2022 | -$0.17 | -$0.58 | -0.41 | $200.72 M | $-40,629,000 |
| 05/05/2022 | Q1 2022 | $3.78 | $3.93 | 0.15 | $811.05 M | $1.23 B |
| 02/28/2022 | Q4 2021 | N/A | $4.01 | N/A | $622.96 M | $812.75 M |
| 11/04/2021 | Q3 2021 | $0.02 | $0.85 | 0.83 | $138.25 M | $103.62 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vir Biotechnology Inc Earnings: FAQ's
In the previous quarter, Vir Biotechnology Inc (:VIR) reported $0.47 earnings per share (EPS) to beat the analysts' consensus estimate of $0.3326 by $0.1374.
The conference call for Vir Biotechnology Inc's latest earnings report can be listened to online.
The conference call transcript for Vir Biotechnology Inc's latest earnings report can be read online.
Vir Biotechnology Inc (:VIR) has a recorded annual revenue of $68.56 M.
Vir Biotechnology Inc (:VIR) has a recorded net income of $-437,987,000.Vir Biotechnology Inc has generated $-3.16 earnings per share over the last four quarters.
Vir Biotechnology Inc (:VIR) has a price-to-earnings ratio of -4.74 and price/earnings-to-growth ratio is -0.06.